Vascular Macrophages in Atherosclerosis

Area of Science:

• Immunology
• Cardiovascular Medicine
• Pathology

Background:

• Atherosclerosis is a primary cause of cardiovascular diseases, posing a significant global health burden.
• It is characterized as a chronic, inflammatory process involving both innate and adaptive immunity.
• Macrophages are central immune cells within atherosclerotic lesions, critical throughout disease progression.

Purpose of the Study:

• To review the multifaceted roles of macrophages in various stages of atherosclerosis.
• To explore the diverse phenotypes and functions of macrophage subsets within atherosclerotic plaques.
• To discuss emerging therapeutic strategies targeting macrophage-driven inflammation.

Main Methods:

• Literature review focusing on macrophage biology in atherosclerosis.
• Analysis of studies detailing macrophage phenotypes and functions in different disease stages.
• Synthesis of current research on macrophage-centric anti-atherosclerosis treatments.

Main Results:

• Macrophages are pivotal in atherosclerosis initiation, progression, and plaque development.
• Macrophage phenotypes exhibit significant heterogeneity, influenced by the plaque microenvironment.
• Targeting macrophage inflammation presents a promising avenue for novel therapeutic interventions.

Conclusions:

• Understanding macrophage dynamics in atherosclerosis is crucial for developing effective treatments.
• Modulating macrophage phenotypes and inflammatory responses holds potential for combating cardiovascular disease.
• Macrophage-targeted therapies represent a significant advancement in anti-atherosclerosis strategies.